Legal framework for beauty products

Terrorized supplies materials for beauty and cosmetic use. Products are not sold as medicines, foods, cosmetics, or dietary supplements, and they are not offered for human or animal consumption, clinical treatment, diagnostic use, or household use.

That intended-use boundary is repeated on product pages, checkout, terms, and notices so the commercial purpose is clear: product supply — not consumer wellness retail and not pharmacy dispensing.

• No dosing or personal-use guidance
• No disease treatment or cure claims
• Accounts and researcher-type collection for professional buyers
• COA-oriented documentation culture for lab records

The primary U.S. federal statute governing drugs, foods, cosmetics, and related products is the Federal Food, Drug, and Cosmetic Act, codified largely in Title 21 of the U.S. Code.

Key idea: whether a product is regulated as a “drug” depends heavily on intended use — including labeling, marketing, and how the seller presents the product — not only on chemical structure. See definitions in 21 U.S.C. § 321.

New drugs / unapproved drugs: Under 21 U.S.C. § 355 (Section 505), a “new drug” generally may not be introduced into interstate commerce without an effective FDA approval (or another applicable legal pathway). Selling an unapproved product as a drug for human use is the classic Section 505 problem.

Why research positioning matters: Our catalog is not marketed with human-use claims, dosing regimens, or therapeutic promises. Materials are framed as reagents for beauty product. That is the core compliance posture: avoid presenting unapproved compounds as ready-to-use medicines.

Misbranding: 21 U.S.C. § 352 addresses misbranded drugs (for example, false or misleading labeling). Clear research-use labeling and the absence of consumer-drug claims are intended to keep the product presentation consistent with product supply rather than pharmaceutical marketing.

Prohibited acts: 21 U.S.C. § 331 lists prohibited introductions into interstate commerce. Compliance programs for product suppliers focus on lawful classification, truthful labeling, and not marketing unapproved drugs for human consumption.

Clinical investigations of unapproved drugs in humans generally require an Investigational New Drug (IND) pathway under 21 U.S.C. § 355(i) and 21 C.F.R. Part 312.

Terrorized is a research-materials storefront, not a clinical trial sponsor and not a pharmacy. We do not authorize human clinical use. Buyers who conduct regulated research are responsible for their own institutional review, laboratory compliance, and any IND or related obligations.

The Controlled Substances Act (21 U.S.C. § 801 et seq.; definitions at § 802) schedules certain substances and restricts manufacture, distribution, and possession according to schedule and registration rules.

Important distinction: being a “beauty peptide” is not the same as being a controlled substance. Many beauty materials are not CSA-scheduled. Conversely, if a substance is controlled, CSA rules apply regardless of “beauty products” language. We do not offer products for the purpose of violating controlled substance laws.

Buyers must verify that any material they purchase is lawful to possess and use in their jurisdiction and under their institutional authority.

The Dietary Supplement Health and Education Act of 1994 (DSHEA) created a framework for dietary supplements under the FD&C Act (see related definitions in 21 U.S.C. § 321(ff)).

Research peptides sold as laboratory reagents are generally not marketed as dietary supplements on this storefront. We do not present catalog materials as vitamins, minerals, herbs, or conventional “supplement facts” consumer products. Keeping clear of supplement-style human-use marketing is part of remaining in a research-supply lane rather than a consumer health-product lane.

It means we sell for laboratory research applications, with labeling and site copy that reject human consumption and medical claims.

It does not mean buyers may ignore the law, import restrictions, institutional bans, or controlled-substance rules. A disclaimer is not a license to misuse materials. FDA and other authorities have, in various contexts, challenged products when overall marketing and reality indicate human-use intent despite “not for human consumption” language.

That is why our policies, checkout notices, and support rules forbid dosing advice and personal-use guidance: intended use must stay beauty product.

By purchasing, buyers are responsible for:

• Confirming local, state, federal, and institutional rules allow possession
• Lawful import/export and customs compliance when shipping internationally
• Proper laboratory handling, storage, and documentation (for example COAs)
• Not using materials for human or animal consumption or unapproved clinical use

See also our research-use buyer guide, Terms of Service, and Trust & safety.

In short: U.S. federal drug law focuses on intended use and approval status. Marketing unapproved compounds as drugs for people triggers Section 505 and related misbranding/prohibited-act analysis. Terrorized operates as a beauty product supplier — not as a pharmacy, supplement brand, or clinical provider — with explicit beauty-product terms.

This page documents that framework for transparency. It is not a substitute for legal counsel. For order or documentation questions, use Contact.